Acyclovir in the prevention of duodenal ulcer recurrence. 1990

S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
Department of Medical Gastroenterology, Glostrup Hospital, Denmark.

This study tests the hypothesis that reactivation of a latent herpes simplex virus infection may be a cause of recurrent duodenal ulceration. Patients with recently healed duodenal ulcer were entered into a double blind, randomised study of maintenance treatment with the antiviral drug acyclovir (400 mg bid) versus placebo, to determine if suppression of herpes virus infection would influence the natural history of the ulcer disease. One hundred and fifteen patients entered the trial and 76 patients completed it according to the protocol. Endoscopy was performed when ulcer symptoms recurred and at the end of the 25 week trial period. In the acyclovir group the cumulated relapse rate was 63% compared with 56% in the placebo group (NS). This result suggests that reactivation of herpes simplex virus is not a cause of recurrent duodenal ulcer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005260 Female Females
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical

Related Publications

S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
November 1986, Annals of internal medicine,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
January 1996, The National medical journal of India,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
June 1987, Therapeutische Umschau. Revue therapeutique,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
April 1988, Zeitschrift fur Gastroenterologie. Verhandlungsband,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
January 1988, Zeitschrift fur arztliche Fortbildung,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
April 1994, Ugeskrift for laeger,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
March 1991, Presse medicale (Paris, France : 1983),
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
January 1990, Gastroenterologie clinique et biologique,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
January 1994, Klinicheskaia khirurgiia,
S J Rune, and J Linde, and O Bonnevie, and H D Petersen, and F Bendtsen, and J H Wandall, and C Gluud, and J Eriksen, and H Skovbjerg, and M Vilien
September 1987, The American journal of medicine,
Copied contents to your clipboard!